CD8A and neoplasm: Another tumour-transplanted mouse analysis of combined RT with anti-PD-L1 antibody treatment demonstrated that the number of MDSCs and Tregs in the tumour decreased, whereas the number of CD8-positive T cells increased, suggesting that the control of immunosuppression by combined treatment can contribute to the inhibition of tumour growth [58].